Late Breaking Lab News
February 13, 2023, Intelligence: Late-Breaking Lab News
By Scott Wallask | From the Volume XXX No. 3 – February 13, 2023 Issue
Laboratory leaders should prepare now for the end of the federal public health emergency (PHE) for SARS-CoV-2. The White House announced the PHE would cease on May 11. One big change is that patients covered by Medicare, Medicaid, or private insurance may pay higher costs for COVID-19 t…
January 23, 2023, Intelligence: Late-Breaking Lab News
By Scott Wallask | From the Volume XXX No. 2 – January 23, 2023 Issue
New data from the Association of American Medical Colleges (AAMC) offers further evidence of a decreasing talent pool of pathologists in the United States. Active physicians in anatomic and clinical pathology dropped from 13,201 in 2016 to 12,180 in 2021—a 7.7% decrease, according to the AAM…
January 3, 2023, Intelligence: Late-Breaking Lab News
By Scott Wallask | From the Volume XXX, No. 1 – January 3, 2023 Issue
At the moment, it appears that the controversial Verifying Accurate Leading-edge IVCT Development (VALID) Act will have a hard time passing in Congress. The bill, which is intended to shift regulation of laboratory-developed tests (LDTs) to the federal Food and Drug Administration…
December 12, 2022, Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXIX, No. 17 – December 12, 2022 Issue
Is it time to allow consumers to do at-home testing for influenza? Given the already-raging influenza season—flu-related hospitalizations doubled the week of Nov. 20 compared to a week earlier, according to the Centers for Disease Control and Prevention—the STAT medical news site ra…
November 21, 2022, Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXIX, No. 16 – November 21, 2022 Issue
In yet another employment ripple from the pandemic, a group of more than 75 pathologists penned a letter to Congress urging lawmakers to retain the option for remote diagnostic work. In the letter, which appeared in the Oct. 20 issue of Nature, the pathologists wrote, “During the COVID-19 pa…
October 31, 2022, Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXIX, No. 15 – October 31, 2022 Issue
Clinical laboratories may soon face increasing pressure to test for respiratory syncytial virus (RSV) now that the public has become aware of the pathogen. Over the past month, there has been an onslaught of media attention on RSV. The coverage has often focused on how this common virus could tag…
October 10, 2022 Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXIX, No. 14 – October 10, 2022 Issue
Future regulation of laboratory-developed tests (LDTs) may not be as clear as it once appeared. On Sept. 30, Congress passed a short-term resolution to keep the federal government funded. As part of the move, a proposed bill to increase oversight of LDTs has been sidelined, at least for now, accordin…
September 19, 2022 Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXIX, No. 13 – September 19, 2022 Issue
Déjà vu? Lawmakers in Congress question whether public health officials have done enough to stay ahead of monkeypox, including the availability of diagnostic tests. Concerns about such testing came up during a Sept. 14 hearing before the Senate’s Health, Education, Labor, and Pensions Committee. …
August 29, 2022 Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXIX, No. 12 – August 29, 2022 Issue
Interesting things may be unfolding in the genetic testing marketplace. In the past few weeks, at least two high-profile genetic testing companies announced major layoffs. First was Invitae, a genetics testing company in San Francisco. At the end of July, it announced plans to eliminate 1,000 …
August 8, 2022 Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXIX, No. 11 – August 8, 2022 Issue
One of the biggest health insurers in the United States has changed its name. As of June 28, Anthem in Indianapolis, Ind., is now known as Elevance Health. The new name is a combination of “elevate” and “advance,” noted Modern Health Executive on June 16. Elevance also an…
CURRENT ISSUE
Volume XXXI, No. 5 – April 8, 2024
The fragmentation of consumer markets is reflected in clinical lab services, and The Dark Report examines this trend and how it will impact labs in the coming years. Also, The Dark Report notes that the FDA has issued a controversial memo to reclassify many high-risk IVD assays.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized